CSRF in Darktrace Enterprise Immune System
CVE-2019-9596
Darktrace Enterprise Immune System before 3.1 allows CSRF via the /whitelisteddomains endpoint.
Vulnerability class: CSRF (Cross-Site Request Forgery)
EPSS: 0.016 (73.6th percentile) — read the EPSS interpretation.
CVSS v3 metric
CVSS v3 base score 6.5 (Medium). Vector: CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:N/I:H/A:N.
Affected products
- Darktrace Enterprise_immune_system
- N/a — versions n/a
Weakness classification (CWE)
Public proof-of-concept exploits
References
- cve@mitre.org (mailing-list, Exploit, x_refsource_BUGTRAQ, Mailing List, Third Party Advisory)
- cve@mitre.org (Exploit, VDB Entry, Third Party Advisory, x_refsource_MISC)
- cve@mitre.org (Technical Description, Exploit, Third Party Advisory, x_refsource_MISC)
- cve@mitre.org (Exploit, Third Party Advisory, x_refsource_MISC)
Frequently asked questions
- What is CVE-2019-9596?
- CVE-2019-9596 is a medium-severity vulnerability in Darktrace Enterprise Immune System, classified under Cross-Site Request Forgery (CSRF). CVSS score: 6.5/10. Published 2019-10-23.
- How severe is CVE-2019-9596?
- Medium severity. CVSS v3 base score is 6.5 out of 10.
- Is CVE-2019-9596 known to be exploited?
- 5 public proof-of-concept repositories are indexed. Not currently listed in the CISA KEV catalog.